Skip to main content
. Author manuscript; available in PMC: 2013 Apr 5.
Published in final edited form as: Mol Endocrinol. 2006 Aug 10;20(12):3133–3145. doi: 10.1210/me.2006-0126

Figure 7. NaBu treatment of mPAC/Pdx cells enhances histone acetylation, but not accessibility to Pdx-1 at the insulin gene.

Figure 7

A, Recovery of the proximal insulin promoter (-126 to -296 bp relative to the transcriptional start site) following quantitative ChIP using Pdx-1 antibody; mPAC/Pdx cells were treated with vehicle (control) or 2.5 mM NaBu for 24 h. B, recovery of the proximal insulin promoter following ChIP using antibodies to acetylated H3 and acetylated H4; mPAC/Pdx cells were treated with vehicle (control) or NaBu for 24 h. All data represent the mean ± S.E. of three independent ChIP experiments